Cornerstone Wealth Group LLC Grows Stock Holdings in Cigna Group $CI

Cornerstone Wealth Group LLC raised its stake in Cigna Group (NYSE:CI) by 4.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,410 shares of the health services provider’s stock after buying an additional 133 shares during the period. Cornerstone Wealth Group LLC’s holdings in Cigna Group were worth $1,127,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Flaharty Asset Management LLC purchased a new stake in shares of Cigna Group in the 1st quarter worth approximately $28,000. 1248 Management LLC purchased a new stake in shares of Cigna Group in the 1st quarter worth approximately $29,000. Activest Wealth Management lifted its position in shares of Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock worth $30,000 after purchasing an additional 72 shares during the period. Retirement Wealth Solutions LLC lifted its position in shares of Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider’s stock worth $33,000 after purchasing an additional 43 shares during the period. Finally, Saudi Central Bank purchased a new stake in shares of Cigna Group in the 1st quarter worth approximately $36,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group Trading Down 1.7%

NYSE CI opened at $295.60 on Tuesday. The company has a quick ratio of 0.71, a current ratio of 0.71 and a debt-to-equity ratio of 0.65. The firm has a market cap of $78.90 billion, a PE ratio of 16.14, a price-to-earnings-growth ratio of 0.88 and a beta of 0.45. The company has a 50 day moving average price of $295.25 and a 200 day moving average price of $308.92. Cigna Group has a 52 week low of $256.89 and a 52 week high of $358.88.

Cigna Group (NYSE:CI) last issued its quarterly earnings results on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion for the quarter, compared to analyst estimates of $62.61 billion. During the same quarter in the prior year, the business posted $6.72 EPS. Cigna Group’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. The ex-dividend date was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.0%. Cigna Group’s dividend payout ratio is presently 32.97%.

Insider Buying and Selling

In other Cigna Group news, insider Brian C. Evanko sold 5,368 shares of the company’s stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total transaction of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 28,526 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on CI shares. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday, October 8th. Guggenheim reaffirmed a “buy” rating and issued a $350.00 price target (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Cantor Fitzgerald reiterated an “overweight” rating and set a $365.00 price objective on shares of Cigna Group in a research note on Tuesday, August 26th. Finally, Barclays boosted their price objective on shares of Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $372.69.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.